syndig1l Antibody

What is SynDIG1 and why is it important in neuroscience research?

SynDIG1 (Synapse Differentiation Induced Gene 1) is a highly conserved type II integral membrane protein that plays a crucial role in excitatory synapse development and maturation. It belongs to the interferon-induced transmembrane family of proteins (IFITM) and is also known as Transmembrane Protein 90B (Tmem90b) .

SynDIG1 is particularly important in neuroscience research because:

• It regulates AMPA receptor function and trafficking at excitatory synapses

• It influences the structural maturation of excitatory synapses in the hippocampus

• It affects postsynaptic density (PSD) length and synapse number

• Its loss results in decreased AMPA and NMDA receptor function in hippocampal neurons

• It interacts directly with AMPA receptors as demonstrated by co-immunoprecipitation studies

The protein is expressed predominantly in the brain, with particular enrichment in the hippocampus, cortex, hindbrain, and spinal cord, making it a valuable target for studies of synaptic plasticity and development .

What is the molecular structure and topology of SynDIG1?

SynDIG1 has a distinctive topology and structure that influences its function:

• It is a type II integral membrane protein with a calculated molecular weight of 28.5 kDa, though it typically appears at approximately 30-36 kDa on western blots

• SynDIG1 has a large intracellular N-terminal region, followed by a single transmembrane domain and a second hydrophobic segment that does not span the membrane

• The N-terminal region is cytoplasmic, while the C-terminal region is exposed to the extracellular environment

• Experiments with HA-tagged constructs revealed that the C-terminal region is present at the outer surface of the plasma membrane

• The first hydrophobic segment spans the plasma membrane, while the second hydrophobic segment is embedded in the outer region of the plasma membrane without traversing it

• The protein shuttles between the cell surface and early endosomes (as determined by colocalization with EEA1) in heterologous cells

This topology is critical for understanding SynDIG1's interactions with other synaptic proteins, particularly AMPA receptors.

What types of SynDIG1 antibodies are available for research?

Several SynDIG1 antibodies have been developed for research purposes:

• Monoclonal antibodies such as L42/17, which is raised against the N-terminal region of the molecule

• Antibodies that recognize specific epitopes within the N-terminal region (amino acids 1-183) of SynDIG1

• Antibodies suitable for various applications including Western blotting (WB) and immunocytochemistry (ICC)

The L42/17 monoclonal antibody specifically:

• Is an IgG2a isotype

• Is generated against a fusion protein containing amino acids 1-183 of the cytoplasmic N-terminus of mouse SynDIG1

• Recognizes human, mouse, and rat SynDIG1

• Is effective at detecting the expected 36 kDa band in Western blot analyses

• Has been validated in rat brain lysate and shows no reported cross-reactivity with other proteins

Understanding the specificity of these antibodies is essential for selecting the appropriate tool for specific experimental applications.

How does SynDIG1 regulate AMPA receptor function and trafficking?

SynDIG1 plays a sophisticated role in regulating AMPA receptor function through several mechanisms:

• SynDIG1 physically interacts with AMPA receptors, as demonstrated by co-immunoprecipitation experiments where anti-GluA2 antibodies efficiently co-precipitate HA-SynDIG1

• The C-terminal region of SynDIG1 is critical for this interaction, as deletion of 33 amino acids from the C-terminus (including the second hydrophobic domain) abolishes co-immunoprecipitation with GluA2

• In vivo studies show that SynDIG1 antibodies co-immunoprecipitate GluA1 and GluA2 but not NR1 from mouse brain extracts, suggesting a selective association with AMPA receptors rather than NMDA receptors

• Overexpression of SynDIG1 in dissociated rat hippocampal neurons increases excitatory synapse strength and number, with increased postsynaptic PSD-95 and AMPA receptors at synapses

• Conversely, knockdown of SynDIG1 decreases synaptic PSD-95 and AMPA receptor levels

• SynDIG1-deficient mice show decreased AMPA receptor function in hippocampal neurons, confirming its role in regulating these receptors in vivo

These findings establish SynDIG1 as a key regulator of AMPA receptor trafficking and function at excitatory synapses, making SynDIG1 antibodies valuable tools for studying the molecular mechanisms of synaptic plasticity.

What is the role of SynDIG1 in synapse development and maturation?

SynDIG1 plays multiple critical roles in synapse development and maturation:

• It progressively accumulates at developing synapses during neuronal maturation. At 7 DIV, 48% of synapses contain SynDIG1, increasing to 64% at 10 DIV, and stabilizing at 56% by 15 DIV

• SynDIG1 is enriched specifically at excitatory synapses, as defined by overlap with postsynaptic (SAP102) and presynaptic (vGlut1) markers, but not at inhibitory synapses

• Ultrastructural analysis of hippocampal CA1 region in SynDIG1 mutant mice reveals decreased average postsynaptic density (PSD) length and reduced number of mature synapses

• Intriguingly, the total synapse number appears increased in SynDIG1 mutant mice, suggesting a role in synapse pruning or maturation rather than initial formation

• Glutamate stimulation of individual dendritic spines in hippocampal slices from SynDIG1-deficient mice shows increased short-term structural plasticity

• Activity-dependent synapse development is strongly compromised upon the loss of SynDIG1, supporting its importance for excitatory synapse maturation

These findings suggest that SynDIG1 functions as a key regulator of excitatory synapse maturation by coordinating structural and functional development of postsynaptic specializations.

What contradictions exist in the literature regarding SynDIG1's regulation of NMDA receptors?

The literature reveals interesting contradictions regarding SynDIG1's regulation of NMDA receptors:

These contradictions highlight the complexity of synaptic protein interactions and emphasize the importance of using multiple experimental approaches when investigating SynDIG1's function.

What are the optimal protocols for using SynDIG1 antibodies in biochemical fractionation experiments?

For effective biochemical fractionation experiments with SynDIG1 antibodies:

• Sample Preparation:

  • Use fresh brain tissue from appropriate age mice (P14 works well for developmental studies)

  • Process tissue through standard subcellular fractionation protocols to isolate:

    • S1 (total homogenate)

    • S2 (cytosolic fraction)

    • P2 (crude membrane fraction)

    • Syn (synaptosomal fraction)

    • S3 (synaptic cytosolic fraction)

    • PSD (postsynaptic density-enriched fraction)

• Antibody Application:

  • For Western blotting, use SynDIG1 antibodies at approximately 1:1000 dilution

  • Include control markers to verify fraction purity:

    • PSD-95 (should be enriched in PSD fraction, diminished in S3)

    • Synaptophysin (should be enriched in Syn and S3 fractions, absent in PSD)

• Data Validation:

  • SynDIG1 should be detectable in S1, S2, P2, Syn, S3, and PSD-enriched fractions in wild-type samples

  • When analyzing SynDIG1 mutants, carefully assess partial protein products that might remain expressed

  • Use quantitative methods like LI-COR for more precise quantification of protein levels

This approach allows for comprehensive analysis of SynDIG1 distribution across different subcellular compartments, providing insights into its trafficking and localization.

What are the best practices for immunocytochemical detection of SynDIG1 in neurons?

For optimal immunocytochemical detection of SynDIG1 in neurons:

• Cell Culture Preparation:

  • Dissociated rat or mouse hippocampal neurons at different developmental stages (2-21 DIV) allow for assessment of temporal expression patterns

  • For co-localization studies, cultures of appropriate age should be selected based on synapse development stage (7-15 DIV optimal for excitatory synapse studies)

• Fixation and Staining Protocol:

  • Standard paraformaldehyde fixation (4%, 10-15 minutes at room temperature)

  • For co-localization studies, use antibodies against:

    • MAP2 to identify dendrites

    • vGlut1 as a presynaptic excitatory marker

    • SAP102 as a postsynaptic excitatory marker

  • Use L42/17 SynDIG1 antibody at a 1:200 dilution for optimal results

• Imaging and Analysis:

  • High-resolution confocal microscopy is recommended for detailed analysis of synaptic localization

  • Two distinct patterns of SynDIG1 immunoreactivity should be observed in mature neurons:

    • Diffuse and punctate staining along dendritic shafts (especially in thick primary dendrites)

    • Distinct staining in dendritic protrusions

  • Quantify co-localization with synaptic markers using established methods (e.g., percent overlap of SynDIG1 puncta with vGlut1/SAP102 co-localized puncta)

  • At mature stages (15 DIV), approximately 56% of excitatory synapses should contain SynDIG1

These practices enable accurate assessment of SynDIG1 localization and its developmental regulation at excitatory synapses.

How can researchers effectively evaluate SynDIG1 antibody specificity?

Thorough evaluation of SynDIG1 antibody specificity is critical for reliable experimental results:

• Heterologous Expression Systems:

  • Express tagged versions of SynDIG1 (e.g., HA-SynDIG1) in COS or HEK293 cells

  • Compare immunostaining patterns between anti-tag antibodies and anti-SynDIG1 antibodies

  • Identical staining patterns indicate antibody specificity

• Deletion Construct Analysis:

  • Generate deletion constructs of SynDIG1 to map epitope recognition:

    • N-terminal deletions (e.g., HA-SynDIG1ΔN75)

    • C-terminal deletions (e.g., HA-SynDIG1ΔC33)

  • Test antibody reactivity against these constructs to determine epitope location

  • For example, L42/17 mAb loses immunoreactivity with the N-terminal deletion construct but retains recognition of the C-terminal deletion construct

• Immunoblot Validation:

  • Compare immunoreactivity in extracts from:

    • Transfected cells expressing HA-SynDIG1 versus vector controls

    • Brain extracts from wild-type versus SynDIG1 knockout/mutant animals

    • Dissociated neuronal cultures

  • A single immunoreactive band at the appropriate molecular weight (~30-36 kDa) indicates specificity

• Knockout/Mutant Controls:

  • Include tissue from genetic models with SynDIG1 deletion or mutation

  • Assess complete loss or specific reduction of signal in mutant samples

  • Be aware that some genetic models may retain partial protein products (as seen with the Δexon4 conditional allele)

• Quality Control Standards:

  • Each new lot of antibody should be tested by Western blot on appropriate tissue (e.g., rat whole brain lysate)

  • Confirm staining of the expected molecular weight band

These rigorous validation steps ensure experimental reliability and interpretability when using SynDIG1 antibodies.